American Bio Medica Corp. (ABMC) - OTCPK - Current
  • Mon, May 16, 11:56 AM
    | Mon, May 16, 11:56 AM
  • Wed, Mar. 30, 11:28 AM
    | Wed, Mar. 30, 11:28 AM
  • Dec. 29, 2015, 10:41 AM
    • American Bio Medica (OTCPK:ABMC +6.6%) completes its research and development of a rapid urine test that detects the two most common compounds, JWH-018 and JWH-073, found in synthetic marijuana, called "K2" or "Spice." The qualitative test will also detect 16 additional cross-reacting compounds that have concentrations above a certain threshold. The test will detect JWH-073 down to a level of 25 ng/ml, the lowest on the market.
    • The product is for forensic use only. The company is accepting pre-orders now and expects to commence shipments to customers in Q1.
    • Synthetic marijuana is a mixture of herbs, spices or shredded plant material that is sprayed with a synthetic compound chemically similar to THC, the psychoactive ingredient in real marijuana.
    | Dec. 29, 2015, 10:41 AM
  • Aug. 13, 2014, 6:23 PM
    • American Bio Medica (OTCQB:ABMC) Q2 results: Revenues: $1.8M (-23.9%); Operating Expenses: $0.8M (-34.9%); Net Loss: ($41K) (+86.1%); Loss Per Share: ($0.00); Quick Assets: $447K (-30.8%).
    • No financial guidance given.
    | Aug. 13, 2014, 6:23 PM
Company Description
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including some of the world's most effective point-of-collection tests for drugs of abuse.
Sector: Healthcare
Industry: Diagnostic Substances
Country: United States